WS39: Clinical Genetics in Britain: Origins and development (23-Sep-2008)
View/ Open
Series
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.01
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.02
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.03
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.04
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.05
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.06
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.07
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.08
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.09
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.10
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.11
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.12
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.13
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.14
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.15
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.16
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.17
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.18
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.19
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.20
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.21
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.22
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.23
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.24
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.25
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.26
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.27
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.28
History of Modern Biomedicine Witness Seminars (Photo Collection);eWS39.29
Metadata
Show full item recordAbstract
Selection of photos taken at the Witness Seminar “Clinical Genetics in Britain: Origins and development” held by the History of Twentieth Century Medicine Group, 23-Sep-2008. Participants: Ms Chris Barnes, Dr Caroline Berry, Professor Martin Bobrow (chair), Professor John Burn, Dr Ian Lister Cheese, Professor Angus Clarke, Dr Clare Davison, Professor Joy Delhanty, Dr Nick Dennis, Professor Dian Donnai, Professor Alan Emery, Professor George Fraser, Mrs Margaret Fraser Roberts, Professor Peter Harper, Dr Hilary Harris, Professor Rodney Harris, Professor Shirley Hodgson, Dr Alan Johnston, Mrs Ann Kershaw, Mrs Lauren Kerzin-Storrar, Professor Michael Laurence, Professor Ursula Mittwoch, Professor Michael Modell, Professor Marcus Pembrey, Professor Sue Povey, Professor Heather Skirton, Professor Tilli Tansey, and Professor Sir David Weatherall.
Authors
History of Twentieth Century Medicine Group
History of Modern Biomedicine Research Group
Collections
Licence information
Related items
Showing items related by title, author, creator and subject.
-
WS57: Medical Genetics: Development of Ethical Dimensions in Clinical Practice and Research (14-Oct-2014)
History of Twentieth Century Medicine Group; History of Modern Biomedicine Research Group; Farnetti T (06/06/2017)Selection of photos taken at the Witness Seminar “Medical Genetics: Development of Ethical Dimensions in Clinical Practice and Research" held by the History of Modern Biomedicine Research Group, 14-Oct-2014. Participants: ... -
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects.
Jervis, S; Song, H; Lee, A; Dicks, E; Harrington, P; Baynes, C; Manchanda, R; Easton, DF; Jacobs, I; Pharoah, PPD (2015-07)BACKGROUND: Although BRCA1 and BRCA2 mutations account for only ∼27% of the familial aggregation of ovarian cancer (OvC), no OvC risk prediction model currently exists that considers the effects of BRCA1, BRCA2 and other ... -
Genetic screening for gynecological cancer: where are we heading?
Manchanda, R; Jacobs, I (2016-01)The landscape of cancer genetics in gynecological oncology is rapidly changing. The traditional family history-based approach has limitations and misses >50% mutation carriers. This is now being replaced by population-based ...